Berliner Boersenzeitung - MicroVision Announces Third Quarter 2025 Results

EUR -
AED 4.343054
AFN 77.464136
ALL 96.578481
AMD 443.001294
ANG 2.116924
AOA 1084.432259
ARS 1696.425045
AUD 1.722632
AWG 2.13043
AZN 2.015092
BAM 1.955364
BBD 2.363473
BDT 143.548016
BGN 1.986001
BHD 0.442401
BIF 3475.425631
BMD 1.182587
BND 1.500966
BOB 8.109193
BRL 6.256361
BSD 1.173439
BTN 107.717999
BWP 16.277373
BYN 3.32206
BYR 23178.695489
BZD 2.360074
CAD 1.622687
CDF 2578.039008
CHF 0.922409
CLF 0.026073
CLP 1029.489324
CNY 8.24689
CNH 8.21806
COP 4228.657801
CRC 580.770597
CUC 1.182587
CUP 31.338542
CVE 110.240437
CZK 24.267271
DJF 208.973438
DKK 7.466899
DOP 73.933527
DZD 153.154875
EGP 55.703589
ERN 17.738798
ETB 182.791072
FJD 2.661179
FKP 0.870315
GBP 0.866681
GEL 3.18162
GGP 0.870315
GHS 12.79115
GIP 0.870315
GMD 86.329235
GNF 10278.709772
GTQ 9.006993
GYD 245.515296
HKD 9.221278
HNL 30.954103
HRK 7.533317
HTG 153.905708
HUF 382.153287
IDR 19840.785951
ILS 3.707232
IMP 0.870315
INR 108.316693
IQD 1537.357457
IRR 49816.456691
ISK 145.777895
JEP 0.870315
JMD 184.718842
JOD 0.838501
JPY 184.146504
KES 151.256298
KGS 103.416722
KHR 4722.947667
KMF 496.686746
KPW 1064.353704
KRW 1710.387141
KWD 0.362349
KYD 0.977982
KZT 590.738376
LAK 25359.349612
LBP 105085.885516
LKR 363.548997
LRD 217.091629
LSL 18.94048
LTL 3.491871
LVL 0.715335
LYD 7.466336
MAD 10.748905
MDL 19.97255
MGA 5308.817127
MKD 61.616271
MMK 2483.187819
MNT 4218.830116
MOP 9.4253
MRU 46.916546
MUR 54.292994
MVR 18.271409
MWK 2034.84661
MXN 20.533372
MYR 4.736855
MZN 75.57955
NAD 18.94048
NGN 1680.526824
NIO 43.180379
NOK 11.555294
NPR 172.348599
NZD 1.987207
OMR 0.454249
PAB 1.173539
PEN 3.936823
PGK 5.018882
PHP 69.733624
PKR 328.342141
PLN 4.208885
PYG 7847.251532
QAR 4.278347
RON 5.101724
RSD 117.373848
RUB 89.207823
RWF 1711.518652
SAR 4.433442
SBD 9.606873
SCR 16.856244
SDG 711.330129
SEK 10.584272
SGD 1.505082
SHP 0.887246
SLE 28.859447
SLL 24798.24684
SOS 669.450838
SRD 45.081425
STD 24477.153012
STN 24.494542
SVC 10.267712
SYP 13078.904017
SZL 18.935781
THB 36.920787
TJS 10.972155
TMT 4.139053
TND 3.416239
TOP 2.847384
TRY 51.246799
TTD 7.971224
TWD 37.116428
TZS 3004.130641
UAH 50.599026
UGX 4148.075755
USD 1.182587
UYU 44.440098
UZS 14242.826515
VES 416.584326
VND 31036.982812
VUV 141.661813
WST 3.258757
XAF 655.810877
XAG 0.011483
XAU 0.000237
XCD 3.196
XCG 2.114929
XDR 0.815618
XOF 655.810877
XPF 119.331742
YER 281.814608
ZAR 19.0597
ZMK 10644.701884
ZMW 23.02187
ZWL 380.792372
  • SCS

    0.0200

    16.14

    +0.12%

  • RBGPF

    -0.8100

    83.23

    -0.97%

  • NGG

    1.3200

    81.5

    +1.62%

  • VOD

    0.2300

    14.17

    +1.62%

  • RELX

    0.0600

    39.9

    +0.15%

  • CMSC

    0.1000

    23.75

    +0.42%

  • GSK

    0.5000

    49.15

    +1.02%

  • BCE

    0.4900

    25.2

    +1.94%

  • RYCEF

    0.3000

    17.12

    +1.75%

  • BTI

    0.9400

    59.16

    +1.59%

  • RIO

    3.1300

    90.43

    +3.46%

  • BP

    1.1000

    36.53

    +3.01%

  • JRI

    0.0100

    13.68

    +0.07%

  • CMSD

    0.0900

    24.13

    +0.37%

  • BCC

    -1.1800

    84.33

    -1.4%

  • AZN

    1.2600

    92.95

    +1.36%

MicroVision Announces Third Quarter 2025 Results
MicroVision Announces Third Quarter 2025 Results

MicroVision Announces Third Quarter 2025 Results

REDMOND, WASHINGTON / ACCESS Newswire / November 11, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced its third quarter 2025 results.

Text size:

Key Business and Operational Highlights

  • Appointed 30-year industry veteran Glen DeVos as Chief Executive Officer, elevating automotive capabilities.

  • Introduced next generation solid-state lidar sensor, MOVIA S, offering an energy-efficient and cost-effective short-range solution for a wide variety of automotive, industrial, and defense sector applications.

  • Launched industry-disrupting Tri-Lidar Architecture solution, offering an alternative to the lidar industry's myopic focus on single sensor solutions.

  • Executed agreement to acquire Scantinel Photonics, a German developer of long-range FMCW lidar, joining investment and strategic partners in advancing lidar-on-chip solution for commercial vehicle and passenger car markets.

  • Established design office and testing facilities in D.C. area, with engineering expertise in aviation and avionics, accelerating development and time-to-market in defense sector, focused on intelligence, surveillance, and reconnaissance, or ISR, capabilities.

  • Expanded global sales and engineering leadership, bringing decades of experience to sales organization and commercialization discipline.

  • Maintained strong balance sheet, cost-efficient operations, and sound financial practices.

"I've been thrilled to see the Company's momentum and energy these past six weeks, as I stepped into my new role here at MicroVision," said Glen DeVos, MicroVision's Chief Executive Officer. "The Company is making great strides - processing the high level of external interest stemming from the unveiling at IAA Mobility of our next-gen short-range sensor; optimizing perception system value to automotive OEMs by disrupting norms to offer a cost-effective, integrated solution; accelerating our drone-agnostic perception solution and expansion into ISR applications; and collaborating with the EU's photonics ecosystem to bring 1550nm FMCW lidar technology to the commercial vehicle and passenger car markets."

"Based on my experience in the evolution of radar, I'm confident that MicroVision will be a leader in lidar, driving the market to a similar inflection point as we saw when radar became a standard feature in automotive ADAS," continued DeVos. "MicroVision has the product portfolio, engineering excellence, and strategic plan to disrupt the market and I am thrilled to lead MicroVision as we redefine the future of lidar."

Key Financial Highlights for Q3 2025

  • Revenue for the third quarter of 2025 was $0.2 million, flat compared to $0.2 million for the third quarter of 2024, comprised of sales to industrial customers.

  • Total operating expenses for the third quarter of 2025 were $12.0 million, which, after adjusting for non-cash items, remained relatively flat year over year as compared to $15.3 million for the third quarter of 2024.

  • Net loss for the third quarter of 2025 was $14.2 million, or $0.05 per share, which includes $2.2 million of non-cash interest expense related to financings, $1.2 million of severance payments related to CEO transition, $0.7 million related to non-cash unrealized gains on warrants and derivatives, and a negative $1.6 million of non-cash share-based compensation expense (which was negative due to the reversal of expense in connection with the forfeiture of certain executive awards in the period), compared to a net loss of $15.5 million, or $0.07 per share, which includes $2.4 million of non-cash share-based compensation expense for the third quarter of 2024.

  • Adjusted EBITDA for the third quarter of 2025 was a $11.7 million loss, flat compared to a $11.7 million loss for the third quarter of 2024.

  • Cash used in operations in the third quarter of 2025 was $16.5 million, compared to cash used in operations in the third quarter of 2024 of $14.1 million.

  • The Company ended the third quarter of 2025 with $99.5 million in cash and cash equivalents, including investment securities, compared to $74.7 million as of December 31, 2024.

As of September 30, 2025, the Company has access to $76.2 million of additional capital, subject to certain conditions, including $46.2 million under its existing ATM, or at-the-market, facility and $30 million from the remaining commitment pursuant to the convertible note facility.

Conference Call and Webcast: Q3 2025 Results

MicroVision will host a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 1:30 PM PT/4:30 PM ET on Tuesday, November 11, 2025 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on November 11, 2025 and may submit questions HERE in advance of the conference call.

The live webcast can be accessed on the Company's Investor Relations website under the Events tab HERE. The webcast will be archived on the website for future viewing.

About MicroVision

MicroVision is at the forefront of driving the global adoption of innovative perception solutions, with the goal of making mobility and autonomy safer. Our engineering excellence, based in Washington State, Washington D.C., and Hamburg, Germany enables us to develop and supply integrated lidar hardware and perception software solutions. Our proprietary technologies enhance safety and automation across various industrial applications, including robotics, automated warehouses, and agriculture, and are instrumental in the development of autonomous systems. MicroVision's core technology, initially developed for the automotive industry, continues to accelerate advanced driver-assistance systems (ADAS) and autonomous driving. Building on our history of providing technology to the military segment, our target offerings include semi- and fully autonomous airborne and terrestrial sensor systems. With our solid-state lidar technologies, encompassing MEMS-based long-range lidar and flash-based short-range lidar, integrated with our onboard perception software, MicroVision possesses the expertise to deliver safe mobility at the speed of life.

For more information, visit the Company's website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.

MicroVision, MAVIN, MOSAIK, and MOVIA are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Non-GAAP information

To supplement MicroVision's condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures "adjusted EBITDA" and "adjusted Gross Profit." Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; and restructuring costs. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision's past financial reports, and facilitates comparisons with other companies in the Company's industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company's operating results and facilitates comparisons of the Company's core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision's operating performance and the valuation of the Company.

Adjusted EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision's business as determined in accordance with GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.

The Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA.

Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

Forward-Looking Statements

Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for revenue and cash; expense reduction; market position; product portfolio; product and manufacturing capabilities; transaction benefits, conditions, and expected completion; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Investor Relations Contact
Jeff Christensen
Darrow Associates Investor Relations
[email protected]

Media Contact
[email protected]

MicroVision, Inc.
Consolidated Balance Sheets
(In thousands)

September 30,

December 31,

2025

2024

Assets
Current assets
Cash and cash equivalents

$

72,832

$

54,486

Investment securities, available-for-sale

26,676

20,216

Restricted cash, current

328

261

Accounts receivable, net of allowances

40

926

Inventory

8,131

2,294

Other current assets

6,969

4,287

Total current assets

114,976

82,470

Property and equipment, net

6,574

7,061

Operating lease right-of-use assets

15,365

16,746

Restricted cash, net of current portion

1,374

1,500

Intangible assets, net

10,281

10,972

Other assets

2,252

2,412

Total assets

$

150,822

$

121,161

Liabilities and shareholders' equity
Current liabilities
Accounts payable

$

1,339

$

1,132

Accrued liabilities

3,754

2,542

Contract liabilities

147

308

Derivative liability

1,856

14,581

Notes payable, current

28,963

24,248

Operating lease liabilities, current

3,154

2,682

Finance lease liabilities, current

14

-

Other current liabilities

672

458

Total current liabilities

39,899

45,951

Notes payable, net of current portion

-

8,754

Warrant liability

4,059

-

Operating lease liabilities, net of current portion

14,434

15,954

Finance lease liabilities, net of current portion

31

-

Other long-term liabilities

1,680

1,733

Total liabilities

60,103

72,392

Commitments and contingencies
Shareholders' equity
Common stock at par value

302

225

Additional paid-in capital

1,009,272

910,825

Accumulated other comprehensive income

651

-

Accumulated deficit

(919,506

)

(862,281

)

Total shareholders' equity

90,719

48,769

Total liabilities and shareholders' equity

$

150,822

$

121,161

MicroVision, Inc.
Consolidated Statement of Operations
(In thousands, except per share data)

Three months ended September 30,

Nine months ended September 30,

2025

2024

2025

2024

Revenue

$

241

$

190

$

985

$

3,046

Cost of revenue

957

583

2,223

3,414

Gross loss

(716

)

(393

)

(1,238

)

(368

)

Research and development expense

7,978

8,736

23,039

40,251

Sales, marketing, general and administrative expense

4,027

6,599

17,140

23,423

Impairment loss on intangible assets

-

-

-

3,027

Gain on disposal of fixed assets

-

(22

)

-

(22

)

Total operating expenses

12,005

15,313

40,179

66,679

Loss from operations

(12,721

)

(15,706

)

(41,417

)

(67,047

)

Interest expense

(2,197

)

(21

)

(17,270

)

(51

)

Unrealized gain on derivative liability

1,059

-

3,853

-

Unrealized (loss) gain on warrant liability

(326

)

-

2,238

-

Realized loss on debt extinguishment

-

-

(4,654

)

-

Other income

140

318

363

1,764

Net loss before taxes

$

(14,045

)

$

(15,409

)

$

(56,887

)

$

(65,334

)

Income tax expense

(172

)

(108

)

(338

)

(426

)

Net loss

$

(14,217

)

$

(15,517

)

$

(57,225

)

$

(65,760

)

Net loss per share - basic and diluted

(0.05

)

$

(0.07

)

$

(0.22

)

$

(0.32

)

Weighted-average shares outstanding - basic and diluted

295,461

213,004

262,235

206,164

MicroVision, Inc.
Consolidated Statements of Cash Flows
(In thousands)

Nine months ended September 30,

2025

2024

Cash flows from operating activities
Net loss

$

(57,225

)

$

(65,760

)

Adjustments to reconcile net loss to net cash used in operations:
Depreciation and amortization

4,347

5,246

Gain on disposal of fixed assets

-

(22

)

Impairment of intangible assets

-

3,027

Impairment of operating lease right-of-use assets

-

406

Unrealized gain on derivative liability

(3,853

)

-

Unrealized gain on warrant liability

(2,238

)

-

Loss on debt extinguishment

4,654

-

Inventory write-downs

-

127

Non-cash interest expense

7,325

-

Amortization of debt discount and issuance costs on notes payable

9,915

-

Share-based compensation expense

2,248

9,522

Net accretion of premium on short-term investments

(284

)

(776

)

Change in:
Accounts receivable

886

717

Inventory

(5,798

)

(723

)

Other current and non-current assets

(2,170

)

606

Accounts payable

207

(784

)

Accrued liabilities

1,087

(2,747

)

Contract liabilities and other current liabilities

32

109

Operating lease liabilities

(2,188

)

(1,944

)

Other long-term liabilities

(260

)

(488

)

Net cash used in operating activities

(43,315

)

(53,484

)

Cash flows from investing activities
Sales of investment securities

26,688

28,311

Purchases of investment securities

(32,878

)

(25,570

)

Purchases of property and equipment

(435

)

(271

)

Cash paid for Ibeo business combination

-

(6,300

)

Net cash used in investing activities

(6,625

)

(3,830

)

Cash flows from financing activities
Principal payments under finance leases

(10

)

-

Principal payments under notes payable

(5,500

)

-

Proceeds from stock option exercises

-

62

Net proceeds from issuance of common stock and warrants

73,268

26,093

Net cash provided by financing activities

67,758

26,155

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

469

133

Change in cash, cash equivalents, and restricted cash

18,287

(31,026

)

Cash, cash equivalents, and restricted cash at beginning of period

56,247

49,391

Cash, cash equivalents, and restricted cash at end of period

$

74,534

$

18,365

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of September 30, 2025 and 2024:

September 30,

September 30,

2025

2024

Cash and cash equivalents

$

72,832

$

16,523

Restricted cash, current

328

270

Restricted cash, net of current portion

1,374

1,572

Cash, cash equivalents, and restricted cash

$

74,534

$

18,365

MicroVision, Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands)

Three months ended September 30,

Nine months ended September 30,

2025

2024

2025

2024

Reconciliation of Non-GAAP Gross (Loss) Profit:
Gross loss

$

(716

)

$

(393

)

$

(1,238

)

$

(368

)

Share-based compensation expense

-

-

-

-

Amortization of acquired intangibles

290

361

652

1,135

Adjusted Gross (Loss) Profit

$

(426

)

$

(32

)

$

(586

)

$

767

Reconciliation of Non-GAAP Loss:
GAAP Net loss

$

(14,217

)

$

(15,517

)

$

(57,225

)

$

(65,760

)

Interest expense, net

2,057

(462

)

16,907

(1,570

)

Income taxes

172

108

338

426

Depreciation and amortization

1,395

1,676

4,347

5,246

Unrealized gain on derivative liability

(1,059

)

-

(3,853

)

-

Unrealized loss (gain) warrant liability

326

-

(2,238

)

-

Loss on debt extinguishment

-

-

4,654

-

Impairment loss on intangible assets

-

-

-

3,027

Impairment of operating lease right-of-use assets

-

13

-

406

Share-based compensation expense

(1,603

)

2,426

2,248

9,522

Restructuring costs

-

90

-

5,804

Severance expense

1,202

-

1,202

-

Adjusted EBITDA

$

(11,727

)

$

(11,666

)

$

(33,620

)

$

(42,899

)

SOURCE: MicroVision, Inc



View the original press release on ACCESS Newswire

(F.Schuster--BBZ)